2023-07-24T15:12:44-04:00 2022-12-31 263838358 BRINKER SIMPSON & COMPANY LLC 1400 N PROVIDENCE RD BLDG 2 STE 20 MEDIA PA 19063 990 2022-01-01 883216384 TESTER CONSTRUCTION GIVES INC TEST ONE BALA PLAZA - SUITE 618 BALA CYNWYD PA 19004 MICHAEL TESTER PRESIDENT 2023-07-11 MICHAEL TESTER 999009999 false JANE MULLARKEY CPA P00849155 6105445900 2023-07-13 2022 2023-04-26 12:10:37Z X X MICHAEL TESTER 233107 false X TESTERCONSTRUCTION.COM/TC-GIVES X 2022 PA TCGIVES WAS BORN IN MEMORY OF KATHLEEN K. SCHOEMAKER WHO LOST HER BATTLE TO PANCREATIC CANCER IN 2006. TCGIVES WILL RAISE MONEY TO PROMOTE PROGRESS IN THE DIAGNOSIS AND TREATMENT OF PANCREATIC CANCER IN HONOR OF KATHLEEN. EVERY YEAR, MORE THAN 62,000 AMERICANS ARE DIAGNOSED WITH PANCREATIC CANCER, THE THIRD-LEADING CAUSE OF CANCER DEATH IN THE COUNTRY. THROUGH FUNDRAISING EFFORTS TCGIVES, IN PARTNERSHIP WITH JEFFERSON'S SIDNEY KIMMEL CANCER CENTER, WANT TO GIVE THE GIFT OF HOPE TO PATIENTS AND FAMILIES MET WITH A DIAGNOSIS OF PANCREATIC CANCER. 3 3 0 7 0 60275 172832 0 0 233107 150000 0 0 0 0 74610 224610 8497 8497 0 8497 X TCGIVES WAS BORN IN MEMORY OF KATHLEEN K. SCHOEMAKER WHO LOST HER BATTLE TO PANCREATIC CANCER IN 2006. TCGIVES WILL RAISE MONEY TO PROMOTE PROGRESS IN THE DIAGNOSIS AND TREATMENT OF PANCREATIC CANCER IN HONOR OF KATHLEEN. EVERY YEAR, MORE THAN 62,000 AMERICANS ARE DIAGNOSED WITH PANCREATIC CANCER, THE THIRD-LEADING CAUSE OF CANCER DEATH IN THE COUNTRY. THROUGH FUNDRAISING EFFORTS TCGIVES, IN PARTNERSHIP WITH JEFFERSON'S SIDNEY KIMMEL CANCER CENTER, WANT TO GIVE THE GIFT OF HOPE TO PATIENTS AND FAMILIES MET WITH A DIAGNOSIS OF PANCREATIC CANCER. false false 211023 150000 172832 WE ARE AND CONTINUE TO BE OVERWHELMED BY DR. YEO'S TEAMS DEDICATION TO THEIR PATIENTS, THEIR FOCUS ON IMPROVING THEIR PATIENTS QUALITY OF LIFE, AND THEIR COMMITMENT TO FINDING A CURE TO PANCREATIC CANCER. TCG GIVES HAS PARTNERED WITH DR. YEO'S TEAM AND JEFFERSON'S SIDNEY KIMMEL CANCER CENTER THAT WE MAY ADVANCE TREATMENT OPTIONS FOR THOSE DIAGNOSED WITH PANCREATIC CANCER. THIS INITIATIVE SEEKS TO IDENTIFY BIOMARKERS IN EARLY STAGE TUMORS, WHICH CAN IN TURN INFORM TUMOR-SPECIFIC TREATMENT AND POTENTIALLY PREDICT DRUG REPSONSE AND DISEASE RECURRENCE. BIOMARKER TESTING IS NOT COVERED UNDER INSURANCE AND RELIES COMPLETELY ON DONATIONS FROM ORGANIZATIONS LIKE TCG GIVES. THIS RESEARCH WILL ADVANCE PANCREATIC CANCER TREATMENT AND IMPROVE SURVIVAL RATES, UTLIMATELY PROVIDING THE BIGGEST GIFT TO THOSE FACED WITH PANCREATIC CANCER: HOPE. JEFFERSON HAS THE TOP PANCREATIC SURGICAL AND RESEARCH TEAM IN THE COUNTRY, LED BY DR. CHARLES YEO. TCG GIVES PROCEEDS WILL GO DIRECTLY TO DR. YEO'S MOLECULAR PROFILING INITIATIVE. ONE OF THE GOALS OF JEFFERSONS' RESEARCH IS TO PROFILE EACH PATIENT'S TUMOR. AS DESCRIBED BY DR. YEO. "BY PROFILING EACH PATIENT'S TUMOR, WE CAN BETTER TARGET THEIR SPECIFIC CANCER. THIS IS THE DIRECTION OF MODERN, PERSONALIZED ONCOLOGIC CARE, NOT TO MENTION ADVANCES OUR RESEARCH". THERE IS LIMITED FUNDING FROM NIH AND THE AMERICAN CANCER SOCIETY AND THEREFOR JEFFERSON'S RESEARCH TEAM RELIES ON PHILANTHORPY TO CONTINUE TO CREATE FORWARD MOVEMENT IN TREATING THIS DISEASE. 211023 true true false false false false false false false false false false false false false false false false false false false false false false false false false true false false false false false false false false false false false false false false false true false false false false 0 0 0 false false false false false false false false false false false false false false X 3 3 true false false false false false false true true false false true true false true false false false false false PA X JAY FEINMAN 2159710790 ONE BALA PLAZA - SUITE 618 BALA CYNWYD PA 19004 X MICHAEL TESTER PRESIDENT 1.50 X X 0 0 0 KRISTEN TESTER SECRETARY 1.50 X X 0 0 0 MARISSA TESTER TREASURER 1.50 X X 0 0 0 ANNEMARIE TESTER BOARD MEMBER 1.50 X 0 0 0 WILLIAM TESTER BOARD MEMBER 1.50 X 0 0 0 false false false 60275 60275 BENEFIT CONCERT 172832 172832 172832 233107 172832 150000 150000 2275 2275 8559 8559 14988 14988 2201 2201 FOOD AND BEVERAGES 29942 29942 ENTERTAINMENT COSTS 12100 12100 FUNDRAISING FEES 3993 3993 SOFTWARE 552 552 224610 211023 13587 0 8497 0 8497 0 0 X 8497 0 8497 0 8497 8497 X true X false false X 60275 60275 172832 172832 233107 233107 233107 233107 233107 1.00000 0.00000 0.00000 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED true THOMAS JEFFERSON UNIVERSITY HOSPITALS INC 1101 MARKET STREET SUITE 2004 PHILADELPHIA PA 19107 232829095 501C3 150000 CASH CANCER RESEARCH FORM 990 - ORGANIZATION'S MISSION TCGIVES WAS BORN IN MEMORY OF KATHLEEN K. SCHOEMAKER WHO LOST HER BATTLE TO PANCREATIC CANCER IN 2006. TCGIVES WILL RAISE MONEY TO PROMOTE PROGRESS IN THE DIAGNOSIS AND TREATMENT OF PANCREATIC CANCER IN HONOR OF KATHLEEN. EVERY YEAR, MORE THAN 62,000 AMERICANS ARE DIAGNOSED WITH PANCREATIC CANCER, THE THIRD-LEADING CAUSE OF CANCER DEATH IN THE COUNTRY. THROUGH FUNDRAISING EFFORTS TCGIVES, IN PARTNERSHIP WITH JEFFERSON'S SIDNEY KIMMEL CANCER CENTER, WANT TO GIVE THE GIFT OF HOPE TO PATIENTS AND FAMILIES MET WITH A DIAGNOSIS OF PANCREATIC CANCER. FORM 990, PAGE 2, PART III, LINE 4A WE ARE AND CONTINUE TO BE OVERWHELMED BY DR. YEO'S TEAMS DEDICATION TO THEIR PATIENTS, THEIR FOCUS ON IMPROVING THEIR PATIENTS QUALITY OF LIFE, AND THEIR COMMITMENT TO FINDING A CURE TO PANCREATIC CANCER. TCG GIVES HAS PARTNERED WITH DR. YEO'S TEAM AND JEFFERSON'S SIDNEY KIMMEL CANCER CENTER THAT WE MAY ADVANCE TREATMENT OPTIONS FOR THOSE DIAGNOSED WITH PANCREATIC CANCER. THIS INITIATIVE SEEKS TO IDENTIFY BIOMARKERS IN EARLY STAGE TUMORS, WHICH CAN IN TURN INFORM TUMOR-SPECIFIC TREATMENT AND POTENTIALLY PREDICT DRUG REPSONSE AND DISEASE RECURRENCE. BIOMARKER TESTING IS NOT COVERED UNDER INSURANCE AND RELIES COMPLETELY ON DONATIONS FROM ORGANIZATIONS LIKE TCG GIVES. THIS RESEARCH WILL ADVANCE PANCREATIC CANCER TREATMENT AND IMPROVE SURVIVAL RATES, UTLIMATELY PROVIDING THE BIGGEST GIFT TO THOSE FACED WITH PANCREATIC CANCER: HOPE. JEFFERSON HAS THE TOP PANCREATIC SURGICAL AND RESEARCH TEAM IN THE COUNTRY, LED BY DR. CHARLES YEO. TCG GIVES PROCEEDS WILL GO DIRECTLY TO DR. YEO'S MOLECULAR PROFILING INITIATIVE. ONE OF THE GOALS OF JEFFERSONS' RESEARCH IS TO PROFILE EACH PATIENT'S TUMOR. AS DESCRIBED BY DR. YEO. "BY PROFILING EACH PATIENT'S TUMOR, WE CAN BETTER TARGET THEIR SPECIFIC CANCER. THIS IS THE DIRECTION OF MODERN, PERSONALIZED ONCOLOGIC CARE, NOT TO MENTION ADVANCES OUR RESEARCH". THERE IS LIMITED FUNDING FROM NIH AND THE AMERICAN CANCER SOCIETY AND THEREFOR JEFFERSON'S RESEARCH TEAM RELIES ON PHILANTHORPY TO CONTINUE TO CREATE FORWARD MOVEMENT IN TREATING THIS DISEASE. FORM 990, PAGE 6, PART VI, LINE 2 MICHAEL TESTER KRISTEN TESTER PRESIDENT SECRETARY SISTER MICHAEL TESTER MARISSA TESTER PRESIDENT TREASURER SISTER MICHAEL TESTER ANNEMARIE TESTER PRESIDENT BOARD MEMBER WIFE MICHAEL TESTER WILLIAM TESTER PRESIDENT BOARD MEMBER FATHER KRISTEN TESTER MARISSA TESTER SECRETARY TREASURER SISTER KRISTEN TESTER ANNEMARIE TESTER SECRETARY BOARD MEMBER SISTER-IN-LAW KRISTEN TESTER WILLIAM TESTER SECRETARY BOARD MEMBER FATHER MARISSA TESTER ANNEMARIE TESTER TREASURER BOARD MEMBER SISTER-IN-LAW MARISSA TESTER WILLIAM TESTER TREASURER BOARD MEMBER FATHER ANNEMARIE TESTER WILLIAM TESTER BOARD MEMBER BOARD MEMBER DAUGHTER-IN-LAW FORM 990, PAGE 6, PART VI, LINE 11B INTERNAL CFO OF TESTER CONSTRUCTION GROUP WILL REVIEW IN DETAILS. FORM 990, PAGE 6, PART VI, LINE 12C REVIEWED ANNUALLY AT THE BOARD MEETING. FORM 990, PAGE 6, PART VI, LINE 19 NO DOCUMENTS AVAILABLE TO THE PUBLIC TESTER CONSTRUCTION GROUP LLC 1541 RIDGE AVE STE 1 PHILADELPHIA PA 19130 823321554 CONSTRUCTI PA N/A false false false true false false false false false false false false false false false false false false false false TESTER CONSTRUCTION GROUP LLC 1541 RIDGE AVE STE 1 PHILADELPHIA PA 19130 C 60275 FMV